Factors Attenuating Zinc Deficiency Improvement in Direct-Acting Antiviral Agent-Treated Chronic Hepatitis C Virus Infection

Zinc deficiency is frequently observed in chronic liver diseases. However, no studies have focused on the zinc status in chronic hepatitis C (HCV)-infected patients receiving direct-acting antiviral agents (DAAs). In this retrospective study, we assessed the serum zinc status in DAA-treated HCV patients with sustained virologic response for over two years (Zn-2y). Ninety-five patients were enrolled, whose baseline characteristics and blood parameters at DAA therapy initiation were collected. Baseline Zn < 65 µg/dL (odds ratio (OR) = 10.56, p < 0.001) and baseline uric acid (UA) > 5.5 mg/dL (OR = 9.99, p = 0.001) were independent risk factors for Zn-2y deficiency. A decision-tree algorithm classified low-baseline Zn and high-baseline UA as the first two variables, suggesting that baseline hypozincemia and hyperuricemia are prognosticators for long-term zinc deficiency. Baseline Zn was negatively correlated with the Fibrosis-4 (FIB-4) index, while baseline UA was significantly higher in habitual alcohol drinkers. In conclusion, serum zinc levels should be closely monitored, considering that zinc status improvement is related to liver fibrosis regression. Hyperuricemia indicates risks of developing metabolic disorders and subsequent zinc deficiency, for which an adjustment of personal lifestyle or dietary habits should be recommended clinically.

[1]  Wen Zhou,et al.  Compounds containing trace element copper or zinc exhibit as potent hyperuricemia inhibitors via xanthine oxidase inactivation. , 2018, Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements.

[2]  Yan Liu,et al.  Association between Dietary Zinc Intake and Hyperuricemia among Adults in the United States , 2018, Nutrients.

[3]  D. Booth,et al.  The antiviral role of zinc and metallothioneins in hepatitis C infection , 2018, Journal of viral hepatitis.

[4]  T. Kawaguchi,et al.  The Prevalence and Implication of Zinc Deficiency in Patients With Chronic Liver Disease , 2018, Journal of clinical medicine research.

[5]  T. Masaki,et al.  Associations between Zinc Deficiency and Metabolic Abnormalities in Patients with Chronic Liver Disease , 2018, Nutrients.

[6]  M. Pillinger,et al.  Gout and Metabolic Syndrome: a Tangled Web , 2017, Current Rheumatology Reports.

[7]  M. Hassany,et al.  Serum Zinc Deficiency and its Relation to Liver Fibrosis in Chronic HCV: a Real-Life Egyptian Study , 2017, Biological Trace Element Research.

[8]  L. Chambless,et al.  Timing and Type of Alcohol Consumption and the Metabolic Syndrome - ELSA-Brasil , 2016, PloS one.

[9]  Lei Zhao,et al.  Zinc mediated hepatic stellate cell collagen synthesis reduction through TGF-β signaling pathway inhibition. , 2015, International journal of clinical and experimental medicine.

[10]  Shu-guang Gao,et al.  Association between low dietary zinc and hyperuricaemia in middle-aged and older males in China: a cross-sectional study , 2015, BMJ Open.

[11]  T. Kawaguchi,et al.  Effects of branched-chain amino acids and zinc-enriched nutrients on prognosticators in HCV-infected patients: a multicenter randomized controlled trial. , 2015, Molecular medicine reports.

[12]  Ying Zhao,et al.  The Diagnostic Value of the FIB-4 Index for Staging Hepatitis B-Related Fibrosis: A Meta-Analysis , 2014, PloS one.

[13]  A. Craxì,et al.  Hyperuricaemia: another metabolic feature affecting the severity of chronic hepatitis because of HCV infection , 2012, Liver international : official journal of the International Association for the Study of the Liver.

[14]  T. Ishikawa Can zinc enhance response interferon therapy for patients with HCV-related liver disease? , 2012, World journal of gastroenterology.

[15]  C. McClain,et al.  Zinc and liver disease. , 2012, Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition.

[16]  D. Reinhold,et al.  Zinc: A complementary factor in the treatment of chronic hepatitis C? (Review). , 2010, Molecular medicine reports.

[17]  S. Hampton,et al.  The influence of alcohol consumed with a meal on endothelial function in healthy individuals. , 2010, Journal of human nutrition and dietetics : the official journal of the British Dietetic Association.

[18]  J. Daniluk,et al.  Zinc supplementation attenuates ethanol- and acetaldehyde-induced liver stellate cell activation by inhibiting reactive oxygen species (ROS) production and by influencing intracellular signaling. , 2009, Biochemical pharmacology.

[19]  M. Mori,et al.  The possible role of zinc and metallothionein in the liver on the therapeutic effect of IFN-α to hepatitis C patients , 1997, Biological Trace Element Research.

[20]  T. Hibi,et al.  Possible inhibitory effect of oral zinc supplementation on hepatic fibrosis through downregulation of TIMP‐1: A pilot study , 2007, Hepatology research : the official journal of the Japan Society of Hepatology.

[21]  T. Masaki,et al.  Efficacy of zinc administration in patients with hepatitis C virus-related chronic liver disease , 2007, Scandinavian journal of gastroenterology.

[22]  A. Fukushima,et al.  Clinical Significance of Evaluation of Serum Zinc Concentrations in C-Viral Chronic Liver Disease , 2006, Digestive Diseases and Sciences.

[23]  Byung Jin Kim,et al.  Relationship between serum uric acid concentration and insulin resistance and metabolic syndrome. , 2005, Circulation journal : official journal of the Japanese Circulation Society.

[24]  C. Guo,et al.  The effect of zinc supplementation on the treatment of chronic hepatitis C patients with interferon and ribavirin. , 2005, Clinical biochemistry.

[25]  I. Çelik,et al.  Trace elements in viral hepatitis. , 2002, Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements.

[26]  T. Nagamine,et al.  Zinc supplementation enhances the response to interferon therapy in patients with chronic hepatitis C , 2001, Journal of viral hepatitis.

[27]  S. Ansorge,et al.  Serum concentrations of sIL-2R, IL-6, TGF-beta1, neopterin, and zinc in chronic hepatitis C patients treated with interferon-alpha. , 1999, Cytokine.